Related Experiment Video
Updated: Aug 7, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
Finding miRNA-RNA Network Biomarkers for Predicting Metastasis and Prognosis in Cancer
Seokwoo Lee1, Myounghoon Cho1, Byungkyu Park2
1Department of Computer Engineering, Inha University, Incheon 22212, Republic of Korea.
International Journal of Molecular Sciences
|March 11, 2023
Summary
This study identifies differential microRNA-RNA correlations in cancer to predict metastasis. These novel biomarkers improve cancer metastasis and prognosis prediction, aiding treatment selection.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Cancer remains a leading global cause of death, with metastasis being the primary driver of mortality.
- Identifying reliable predictors of metastasis and patient prognosis is crucial for effective cancer treatment.
Purpose of the Study:
- To develop a novel model for predicting cancer metastasis using differential microRNA-RNA correlations.
- To identify prognostic network biomarkers for cancer patients.
Main Methods:
- Analysis of microRNA (miRNA) and RNA correlations in tumor versus normal tissue samples.
- Construction of predictive models for lymph node and distant metastasis based on differential miRNA-RNA correlations.
- Utilizing miRNA-RNA correlations to identify prognostic network biomarkers.
Main Results:
- The developed model significantly outperformed existing models in predicting both lymph node and distant metastasis.
- Differential miRNA-RNA correlations and associated networks demonstrated superior power in predicting patient prognosis.
- Identified novel miRNA-RNA pairs as potential biomarkers for metastasis and prognosis.
Conclusions:
- Differential miRNA-RNA correlations offer a powerful approach for predicting cancer metastasis and patient prognosis.
- The identified biomarkers can guide treatment selection and inform anti-cancer drug discovery.
- This method holds promise for improving clinical outcomes in cancer patients.
Related Concept Videos
MicroRNAs
21.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.4K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

